Detalhe da pesquisa
1.
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Lancet;
400(10353): 680-690, 2022 08 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36007534
2.
The GLP-1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes.
Clin Endocrinol (Oxf);
99(4): 401-408, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36843143
3.
The prevalence and significance of nonuniform thyroid radio-isotope uptake in patients with Graves' disease.
Clin Endocrinol (Oxf);
97(1): 100-105, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35244288
4.
Frequency, determinants and costs of thyroid function testing in a laboratory serving a large population.
Eur J Endocrinol;
186(5): 553-560, 2022 Mar 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35275844
5.
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Health Technol Assess;
26(39): 1-100, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36259684
6.
Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease.
J Clin Endocrinol Metab;
104(5): 1378-1385, 2019 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30517711
7.
The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds.
Thyroid;
26(6): 765-9, 2016 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27090092